Medical/Pharmaceuticals

Medtecs participates for the first time in world's leading nonwovens exhibition - INDEX(TM)20 in Europe

TAIPEI, Oct. 7, 2021 /PRNewswire/ -- The threat of COVID-19 continues. As vaccine development fails to keep up with the rate the virus mutates, countries around the world have started exploring ways to "coexist with the virus," meaning that personal protective equipment (PPE) such as face masks a...

2021-10-07 21:28 5072

Hummingbird Bioscience to Present Pre-Clinical Data on Novel Biomarkers for HER3-driven Cancers

HOUSTON and SINGAPORE, Oct. 7, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announced the presentation of pre-clinical data on novel biomarkers for HER3-driven cancers at the...

2021-10-07 21:03 2272

Cambrex to Invest $30 Million to Expand Manufacturing Center of Excellence at High Point, NC Facility

EAST RUTHERFORD, N.J., Oct. 7, 2021 /PRNewswire/ -- Cambrex today announced that it is expanding its manufacturing center of excellence inHigh Point, NC. The $30+ million investment is designed to meet the continually growing demand for small molecule development and manufacturing services. The ...

2021-10-07 20:30 3618

CDD Gives Back with Open Access Data Visualization Tool

SAN FRANCISCO, Oct. 7, 2021 /PRNewswire/ -- Collaborative Drug Discovery, Inc. (CDD) announced today that it is providing a full featured, standalone software tool to the scientific community for free.CDD Visualization is an intuitive browser-based application that allows scientists to visualize ...

2021-10-07 17:57 2520

Solving the Mystery of Sleep by "Lighting Up the Brain" presented at WCN 2021 by Neuroscientist Gero Miesenböck

LONDON, Oct. 7, 2021 /PRNewswire/ -- Solving the mystery of sleep by studying brain mechanisms that regulate sleep and waking was research presented by Gero Miesenböck, Waynflete Professor of Physiology at the Centre for Neural Circuits and Behavior,Oxford, England at the virtual 25th Biennial Wo...

2021-10-07 17:46 1788

Deep Longevity Launches Longevity Medicine Course for Physicians with Industry Experts

HONG KONG, Oct. 7, 2021 /PRNewswire/ -- Endurance RP Limited's ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK)'s Deep Longevity, Inc, a company acquired on14 December 2020 which develops artificial intelligence to track human aging and ...

2021-10-07 15:30 11785

Ascensia Diabetes Care Launches the "This is Diabetes" Competition to Highlight the Need for Access to Diabetes Care in Support of IDF's World Diabetes Day

BASEL, Switzerland, Oct. 7, 2021 /PRNewswire/ -- Today Ascensia Diabetes Care, makers of the CONTOUR® Blood Glucose Monitoring system portfolio and distributors of the Eversense® Continuous Glucose Monitoring system, has launched its "This is Diabetes" art and photography competition as the comp...

2021-10-07 15:00 2594

Research on Using Fluid Biomarkers to Advance Drug Treatments and Therapies for Alzheimer's, Traumatic Brain Injury, Concussion, and Other Neurodegenerative Diseases Presented at World Congress of Neurology 2021 by Neuroscientist Henrik Zetterberg

LONDON, Oct. 7, 2021 /PRNewswire/ -- New developments in the field of blood biomarkers for brain diseases including traumatic brain injury (TBI), and neurodegenerative diseases such as Alzheimer's, were unveiled during three lectures at the 25th BiennialWorld Congress of Neurology, October 3–7, 2...

2021-10-07 12:02 2496

Debiopharm and Dexa Medica Launch Triptorelin Collaboration to Bring New Hope to Women With Endometriosis

LAUSANNE, Switzerland and TANGERANG, Indonesia, Oct. 7, 2021 /PRNewswire/ -- Debiopharm (www.debiopharm.com ), a Swiss-based, global biopharmaceutical company, andDexa Medica, a leading Indonesian pharmaceutical company, today announced the Indonesian launch of triptor...

2021-10-07 06:00 2846

Luciole Pharmaceuticals and Cyclica Announce Research Collaboration to Accelerate Discovery of Novel Medicines

NATICK, Mass. and TORONTO, Oct. 7, 2021 /PRNewswire/ -- Luciole Pharmaceuticals, a startup company focused on the discovery and development of small molecules that enhance the repair of oxidative damage to mitochondrial DNA (mtDNA), and Cyclica, the partner of choice for data-driven drug discovery...

2021-10-07 03:56 1970

endpoint and Berlinger Collaborate to Provide Complete Visibility of the Historical Temperature Journey of an IMP

Fully integrated solution: Turn a 25-day manual temperature-monitoring data evaluation into instant decision making SAN FRANCISCO and SWITZERLAND, Oct. 6, 2021 /PRNewswire/ -- endpoint Clinical , the leader in global interactive response technology (IRT®) for clinical trials, andBerlinger & Co. A...

2021-10-06 22:31 6341

Kazia Therapeutics to Present at LD Micro Main Event

SYDNEY, Oct. 6, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that CEO, DrJames Garner, will be presenting at the LD Micro Main Event, to be held virtually and in person from12-14 October 2021. Since...

2021-10-06 22:00 8726

ArisGlobal LifeSphere® MultiVigilance is selected by Asahi Kasei Pharma

MIAMI and TOKYO, Oct. 6, 2021 /PRNewswire/ -- Asahi Kasei Pharma Corp. has selectedLifeSphere® MultiVigilance as a new safety database with the purpose of building a system that supports efficiency, regulatory compliance, and global collaboration over the long term. In addition, Asahi Kasei Pharm...

2021-10-06 11:00 3163

Neopharma Technologies announces wholesale investment round with OnMarket

Targeting full commercilaisation of its patented and world-leading drugs-of-abuse testing technology. OnMarket Live Offer for Professional & Sophisticated Investors: https://www.onmarket.com.au/offers/neopharma-w www.neopharmatec...

2021-10-06 08:46 3922

146th Annual Meeting of the American Neurological Association to Focus on Research and Development of Neurologic Disease Therapeutics

World's Leading Academic Neurologists and Neuroscientists to Present at ANA2021 MOUNT LAUREL, N.J., Oct. 6, 2021 /PRNewswire/ -- This year's Virtual Annual Meeting,ANA2021 will welcome more than 1,000 academic neurologists and neuroscientists from around the world to share exciting research updat...

2021-10-06 07:07 2013

VUNO Signs Another Deal with Samsung Electronics to Incorporate AI-assisted Solutions into Samsung's Premium Ceiling Type Digital Radiography System

SEOUL, South Korea, Oct. 5, 2021 /PRNewswire/ -- South Korean artificial intelligence (AI) developer, VUNO Inc., announced today that the company closed a deal with global medical device manufacturer, Samsung Electronics Co., Ltd., to embed VUNO's artificial intelligence-driven chest X-ray diagno...

2021-10-05 21:00 3882

Renexxion Ireland Ltd. Announces a Licensing and Collaboration Agreement with Dr. Falk Pharma GmbH

ROSCREA, Ireland and FREIBURG, Germany, Oct. 5, 2021 /PRNewswire/ -- Renexxion Ireland Ltd., a private biopharmaceutical company committed to delivering innovative drugs to patients with high unmet need gastrointestinal ("GI") disorders, announced today that it has entered into a Licensing and C...

2021-10-05 20:10 4644

I-Mab and ABL Bio to Present Preclinical Data of TJ-CD4B/ABL111 and TJ-L14B/ABL503 at the 2021 SITC Annual Meeting

SHANGHAI and GAITHERSBURG, Md., Oct. 5, 2021 /PRNewswire/ -- I-Mab (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel or highly differentiated biologics, and ABL Bio, Inc. (Kosdaq:298380, hereafter "ABL"), a South Kor...

2021-10-05 20:00 9700

RhoVac presents 3-year follow-up results of the phase I/II study in prostate cancer

STOCKHOLM, Oct. 5, 2021 /PRNewswire/ -- RhoVac AB ("RhoVac"), a Swedish cancer immunotherapy company, announces today onOctober 5, 2021, that it has received and validated the top line results from its 3-year follow-up of the patients who took part in its phase I/II study that was concluded in 20...

2021-10-05 19:14 1859

Innodem Neurosciences Signs a Strategic Partnership with Novartis Pharmaceuticals Canada Inc.

MONTREAL, Oct. 5, 2021 /PRNewswire/ -- Innodem Neurosciences announced today that it has signed a multi-year partnership agreement with Novartis Pharmaceuticals Canada Inc. (Novartis) to conduct a breakthrough clinical trial to help people living with multiple sclerosis (MS). Innodem's AI-powere...

2021-10-05 19:04 2073
1 ... 619620621622623624625 ... 646

Week's Top Stories